Aerovate Therapeutics Market Cap

Aerovate Therapeutics has a market cap or net worth of $590.70 million as of April 24, 2024. Its market cap has increased by 31.18% in one year.

Market Cap

590.70M

Enterprise Value

524.38M

1-Year Change

31.18%

Ranking

#2748

Market Cap Chart

Since the IPO on June 30, 2021, Aerovate Therapeutics's market cap has increased from $323.51M to $590.70M, an increase of 82.59%. That is a compound annual growth rate of 23.83%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2024	647.00M	4.74%
Apr 22, 2024	617.70M	0.54%
Apr 19, 2024	614.40M	2.09%
Apr 18, 2024	601.80M	-4.00%
Apr 17, 2024	626.90M	-4.74%
Apr 16, 2024	658.10M	-6.64%
Apr 15, 2024	704.90M	0.23%
Apr 12, 2024	703.30M	-6.13%
Apr 11, 2024	749.20M	-0.45%
Apr 10, 2024	752.60M	-3.71%
Apr 9, 2024	781.60M	5.94%
Apr 8, 2024	737.80M	5.70%
Apr 5, 2024	698.00M	-13.91%
Apr 4, 2024	810.80M	-0.07%
Apr 3, 2024	811.40M	-1.55%
Apr 2, 2024	824.20M	-3.80%
Apr 1, 2024	856.80M	3.99%
Mar 28, 2024	823.90M	3.75%
Mar 27, 2024	794.10M	11.11%
Mar 26, 2024	714.70M	-4.82%
Mar 25, 2024	750.90M	5.27%
Mar 22, 2024	713.30M	-0.85%
Mar 21, 2024	719.40M	0.43%
Mar 20, 2024	716.30M	0.66%
Mar 19, 2024	711.60M	-2.55%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	708.35B
Novo Nordisk	559.11B
UnitedHealth Group	448.30B
Johnson & Johnson	361.25B
Merck & Co.	321.37B
AbbVie	299.86B
AstraZeneca	219.68B
Thermo Fisher	219.41B

Market Cap Rankings